34 related articles for article (PubMed ID: 2689396)
1. Regarding Herman et al., IJROBP 17:1273-1278; 1989.
Herman TS
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):897-8. PubMed ID: 7790283
[No Abstract] [Full Text] [Related]
2. Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment.
Ademaj A; Veltsista DP; Ghadjar P; Marder D; Oberacker E; Ott OJ; Wust P; Puric E; Hälg RA; Rogers S; Bodis S; Fietkau R; Crezee H; Riesterer O
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158893
[TBL] [Abstract][Full Text] [Related]
3. Vascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.
Griffin RJ; Williams BW; Koonce NA; Bischof JC; Song CW; Asur R; Upreti M
J Oncol; 2012; 2012():934918. PubMed ID: 22272199
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermia for locally advanced breast cancer.
Zagar TM; Oleson JR; Vujaskovic Z; Dewhirst MW; Craciunescu OI; Blackwell KL; Prosnitz LR; Jones EL
Int J Hyperthermia; 2010; 26(7):618-24. PubMed ID: 20849257
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermia induced NFkappaB mediated apoptosis in normal human monocytes.
Aravindan N; Shanmugasundaram K; Natarajan M
Mol Cell Biochem; 2009 Jul; 327(1-2):29-37. PubMed ID: 19219626
[TBL] [Abstract][Full Text] [Related]
6. Heat enhances the cytotoxicity of cis-diamminedichloroplatinum(II) and its analogues cis-1,1-cyclobutane-dicarboxylato(2R)-2-methyl-1,4- butanediammineplatinum(II) and cis-diammine(glycolato)platinum in vitro.
Takahashi I; Maehara Y; Kusumoto H; Kohnoe S; Sugimachi K
Cancer Chemother Pharmacol; 1993; 33(1):31-5. PubMed ID: 8269586
[TBL] [Abstract][Full Text] [Related]
7. Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.
Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Alvarez Sotomayor E
Cancer Chemother Pharmacol; 1990; 26(2):127-34. PubMed ID: 2347038
[TBL] [Abstract][Full Text] [Related]
8. Initial results of phase I/II interstitial thermoradiotherapy for primary advanced and local recurrent tumors.
Phromratanapongse P; Seegenschmiedt MH; Karlsson UL; Brady LW; Sauer R; Herbst M; Fietkau R
Am J Clin Oncol; 1990 Jun; 13(3):259-68. PubMed ID: 2189290
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia in oncology.
Falk MH; Issels RD
Int J Hyperthermia; 2001; 17(1):1-18. PubMed ID: 11212876
[TBL] [Abstract][Full Text] [Related]
10. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies.
Herman TS; Jochelson MS; Teicher BA; Scott PJ; Hansen J; Clark JR; Pfeffer MR; Gelwan LE; Molnar-Griffin BJ; Fraser SM
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1273-9. PubMed ID: 2689396
[TBL] [Abstract][Full Text] [Related]
11. Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma.
Bornstein BA; Zouranjian PS; Hansen JL; Fraser SM; Gelwan LA; Teicher BA; Svensson GK
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):79-85. PubMed ID: 7677990
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours.
Bornstein BA; Herman TS; Hansen JL; Buswell L; Zouranjian PS; Fraser SM; Teicher BA; Svensson GK; Coleman CN
Int J Hyperthermia; 1995; 11(4):489-99. PubMed ID: 7594803
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I-II study.
Amichetti M; Graiff C; Fellin G; Pani G; Bolner A; Maluta S; Valdagni R
Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):801-7. PubMed ID: 8344849
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy.
Green DM; Burton GV; Cox EB; Hanson D; Moore J; Oleson JR
Int J Hyperthermia; 1989; 5(1):13-21. PubMed ID: 2646381
[TBL] [Abstract][Full Text] [Related]
15. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
